Chargement en cours...
Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study
BACKGROUND: The discovery that nerve growth factor (NGF) metabolism is altered in Down syndrome (DS) and Alzheimer's disease (AD) brains offered a framework for the identification of novel biomarkers signalling NGF deregulation in AD pathology. METHODS: We examined levels of NGF pathway protein...
Enregistré dans:
| Publié dans: | Alzheimers Dement |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8043977/ https://ncbi.nlm.nih.gov/pubmed/33226181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/alz.12229 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|